He Du

617 total citations
26 papers, 323 citations indexed

About

He Du is a scholar working on Molecular Biology, Internal Medicine and Cancer Research. According to data from OpenAlex, He Du has authored 26 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Internal Medicine and 8 papers in Cancer Research. Recurrent topics in He Du's work include Venous Thromboembolism Diagnosis and Management (8 papers), Central Venous Catheters and Hemodialysis (4 papers) and Cancer-related molecular mechanisms research (4 papers). He Du is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (8 papers), Central Venous Catheters and Hemodialysis (4 papers) and Cancer-related molecular mechanisms research (4 papers). He Du collaborates with scholars based in China, Japan and United States. He Du's co-authors include Youwei Zhang, Sanyuan Sun, Wei Xiong, Yunfeng Zhao, Bi Chen, Xuejun Guo, Yanhua Liu, Ke He, Yang Li and Meng Tang and has published in prestigious journals such as Journal of Molecular and Cellular Cardiology, Oncotarget and Frontiers in Pharmacology.

In The Last Decade

He Du

25 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
He Du China 9 186 107 86 79 61 26 323
Yiming Zhao China 10 122 0.7× 64 0.6× 131 1.5× 72 0.9× 39 0.6× 19 293
Cristian Ortiz‐Villalón Sweden 10 138 0.7× 64 0.6× 166 1.9× 86 1.1× 11 0.2× 22 324
Giulia Rovesti Italy 11 123 0.7× 85 0.8× 162 1.9× 50 0.6× 36 0.6× 27 393
Matthew C. Dallos United States 11 163 0.9× 62 0.6× 288 3.3× 170 2.2× 205 3.4× 32 473
Haotian Xu China 10 288 1.5× 233 2.2× 45 0.5× 52 0.7× 23 0.4× 25 372
Yifei Ma China 11 126 0.7× 104 1.0× 87 1.0× 38 0.5× 30 0.5× 33 277
Xiaole Zhu China 10 126 0.7× 79 0.7× 195 2.3× 87 1.1× 43 0.7× 25 390
Tetsuro Kawazoe Japan 6 98 0.5× 67 0.6× 155 1.8× 70 0.9× 46 0.8× 22 295

Countries citing papers authored by He Du

Since Specialization
Citations

This map shows the geographic impact of He Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Du more than expected).

Fields of papers citing papers by He Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by He Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Du. The network helps show where He Du may publish in the future.

Co-authorship network of co-authors of He Du

This figure shows the co-authorship network connecting the top 25 collaborators of He Du. A scholar is included among the top collaborators of He Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He Du. He Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qiao, Hongwei, Yi Cheng, He Du, et al.. (2024). The role of green tea intake in thromboprophylaxis of venous thromboembolism in patients with cancer. Frontiers in Nutrition. 11. 1296774–1296774. 2 indexed citations
3.
Xiu, Weigang, Yuwen Zhou, He Du, et al.. (2023). A nomogram for the prediction of the survival of patients with advanced non‐small cell lung cancer and interstitial lung disease. Cancer Medicine. 12(10). 11375–11384. 3 indexed citations
4.
Xiong, Wei, Xuejun Guo, He Du, Mei Xu, & Yunfeng Zhao. (2023). Management of venous thromboembolism in patients with lung cancer: a state-of-the-art review. BMJ Open Respiratory Research. 10(1). e001493–e001493. 6 indexed citations
5.
Xiong, Wei, Yunfeng Zhao, Yi Cheng, et al.. (2023). Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE. Thrombosis Journal. 21(1). 8–8. 7 indexed citations
6.
7.
Wang, Zijian, Wei Zhu, Meng‐Hang Yang, et al.. (2023). Air bronchogram on chest CT in radiological pure-solid appearance lung cancer: Correlation analysis with genetic pathological features and survival outcomes. European Journal of Radiology. 169. 111194–111194. 3 indexed citations
8.
Wang, Ziyao, He Du, Chen Chen, Xuedong Liu, & Nengwen Ke. (2022). Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report. Frontiers in Oncology. 11. 801320–801320. 7 indexed citations
9.
Xiong, Wei, Yunfeng Zhao, Song Liu, et al.. (2022). Sequential Therapy of Nadroparin and Rivaroxaban in the Initial Treatment of Patients With Acute Pulmonary Embolism. Frontiers in Pharmacology. 13. 810455–810455. 2 indexed citations
10.
Li, Rui, et al.. (2021). Prognostic Nomogram Based on Circular RNA‐Associated Competing Endogenous RNA Network for Patients with Lung Adenocarcinoma. Oxidative Medicine and Cellular Longevity. 2021(1). 9978206–9978206. 8 indexed citations
11.
Li, Pan, Jingwen Song, He Du, et al.. (2021). MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling. Journal of Molecular and Cellular Cardiology. 161. 9–22. 20 indexed citations
12.
Xiong, Wei, Yunfeng Zhao, He Du, & Xuejun Guo. (2021). Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer. Frontiers in Oncology. 11. 704336–704336. 33 indexed citations
13.
Du, He, et al.. (2020). CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA‐146a and microRNA‐26a. Thoracic Cancer. 11(9). 2473–2482. 17 indexed citations
14.
Du, He, Bi Chen, Nanlin Jiao, et al.. (2020). Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma. Oxidative Medicine and Cellular Longevity. 2020. 1–14. 38 indexed citations
15.
Xiong, Wei, He Du, Mei Xu, et al.. (2020). An authoritative algorithm most appropriate for the prediction of pulmonary embolism in patients with AECOPD. Respiratory Research. 21(1). 218–218. 3 indexed citations
16.
Du, He, et al.. (2020). Distinct Prognostic Values of the mRNA Expression of Glucose Transporters in Non-Small Cell Lung Cancer.. PubMed. 50(4). 481–489. 5 indexed citations
17.
Du, He, Hong Li, & Wenjun Guo. (2016). The role low microRNA-335 expression in prognosis prediction of human cancers. Journal of Cancer Research and Therapeutics. 12(2). 1070–1074. 5 indexed citations
18.
Chen, Xin‐Zu, Weihan Zhang, Hai‐Ning Chen, et al.. (2016). Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study. Oncotarget. 7(17). 23647–23657. 10 indexed citations
19.
Ding, Qianshan, He Du, Ke He, et al.. (2015). Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers. Tumor Biology. 36(11). 8761–8772. 59 indexed citations
20.
Zhang, Ling, Wei Ge, Ke Hu, et al.. (2011). Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells. Molecular Biology Reports. 39(1). 89–95. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiming Zhao Breakdown of academic impact, for papers by Cristian Ortiz‐Villalón Breakdown of academic impact, for papers by Giulia Rovesti Breakdown of academic impact, for papers by Matthew C. Dallos Breakdown of academic impact, for papers by Haotian Xu Breakdown of academic impact, for papers by Yifei Ma Breakdown of academic impact, for papers by Xiaole Zhu Breakdown of academic impact, for papers by Tetsuro Kawazoe
Rankless by CCL
2026